<code id='225669C199'></code><style id='225669C199'></style>
    • <acronym id='225669C199'></acronym>
      <center id='225669C199'><center id='225669C199'><tfoot id='225669C199'></tfoot></center><abbr id='225669C199'><dir id='225669C199'><tfoot id='225669C199'></tfoot><noframes id='225669C199'>

    • <optgroup id='225669C199'><strike id='225669C199'><sup id='225669C199'></sup></strike><code id='225669C199'></code></optgroup>
        1. <b id='225669C199'><label id='225669C199'><select id='225669C199'><dt id='225669C199'><span id='225669C199'></span></dt></select></label></b><u id='225669C199'></u>
          <i id='225669C199'><strike id='225669C199'><tt id='225669C199'><pre id='225669C199'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:58
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Medical device trials still don't enroll enough women, study finds
          Medical device trials still don't enroll enough women, study finds

          AdobeWomenhavealwaysbeenunderrepresentedinmedicalresearch.Anewstudyrevealsthatnotmuchhaschanged,espe

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Patients' immediate access to test results puts radiologists in a bind

          AdobeOneofthehardestpartsaboutgettinganX-rayoraCTscanisthewait.Sometimesittakesdays,orevenweeks,form